Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Aurelio Barricarte Gurrea is active.

Publication


Featured researches published by Aurelio Barricarte Gurrea.


Cancer Epidemiology, Biomarkers & Prevention | 2006

Physical Activity and Risk of Colon and Rectal Cancers: The European Prospective Investigation into Cancer and Nutrition

Christine Friedenreich; Teresa Norat; Karen Steindorf; Marie-Christine Boutron-Ruault; Tobias Pischon; Mathieu Mazuir; Françoise Clavel-Chapelon; Jakob Linseisen; Heiner Boeing; Manuela M. Bergman; Nina Føns Johnsen; Anne Tjønneland; Kim Overvad; Michelle A. Mendez; J. Ramón Quirós; Carmen Martinez; Miren Dorronsoro; Carmen Navarro; Aurelio Barricarte Gurrea; Sheila Bingham; Kay-Tee Khaw; Naomi E. Allen; Timothy J. Key; Antonia Trichopoulou; Dimitrios Trichopoulos; Natassa Orfanou; Vittorio Krogh; Domenico Palli; Rosario Tumino; Salvatore Panico

We investigated several aspects of the role of physical activity in colon and rectal cancer etiology that remain unclear in the European Prospective Investigation into Nutrition and Cancer. This cohort of 413,044 men and women had 1,094 cases of colon and 599 cases of rectal cancer diagnosed during an average of 6.4 years of follow-up. We analyzed baseline data on occupational, household, and recreational activity to examine associations by type of activity, tumor subsite, body mass index (BMI), and energy intake. The multivariate hazard ratio for colon cancer was 0.78 [95% confidence interval (95% CI), 0.59-1.03] among the most active participants when compared with the inactive, with evidence of a dose-response effect (Ptrend = 0.04). For right-sided colon tumors, the risk was 0.65 (95% CI, 0.43-1.00) in the highest quartile of activity with evidence of a linear trend (Ptrend = 0.004). Active participants with a BMI under 25 had a risk of 0.63 (95% CI, 0.39-1.01) for colon cancer compared with the inactive. Finally, an interaction between BMI and activity (Pinteraction = 0.03) was observed for right-sided colon cancers; among moderately active and active participants with a BMI under 25, a risk of 0.38 (95% CI, 0.21-0.68) was found as compared with inactive participants with BMI >30. No comparable decreased risks were observed for rectal cancer for any type of physical activity for any subgroup analyses or interactions considered. We found that physical activity reduced colon cancer risk, specifically for right-sided tumors and for lean participants, but not rectal cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(12):2398–407)


International Journal of Cancer | 2010

Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.

Sabina Rinaldi; Rebecca J. Cleveland; Teresa Norat; Carine Biessy; Sabine Rohrmann; Jakob Linseisen; Heiner Boeing; Tobias Pischon; Salvatore Panico; Claudia Agnoli; Domenico Palli; Rosario Tumino; Paolo Vineis; Petra H.M. Peeters; Carla H. van Gils; Bas Bueno-de-Mesquita; Alina Vrieling; Naomi E. Allen; Andrew W. Roddam; Sheila Bingham; Kay-Tee Khaw; Jonas Manjer; Signe Borgquist; Vanessa Dumeaux; Inger Torhild Gram; Eiliv Lund; Antonia Trichopoulou; Georgios Makrygiannis; Vassiliki Benetou; Esther Molina

Several prospective studies have shown a moderate positive association between increasing circulating insulin‐like growth factor‐I (IGF‐I) levels and colorectal cancer risk. However, the associations were often statistically nonsignificant, and the relationship of cancer risk with IGF‐Is major binding protein, IGFBP‐3, showed major discrepancies between studies. We investigated the association of colorectal cancer risk with serum IGF‐I, total and intact IGFBP‐3, in a case‐control study nested within the EPIC cohort (1,121 cases of colorectal cancer and 1,121 matched controls). Conditional logistic regression was used to adjust for possible confounders. Our present study results were combined in a meta‐analysis with those from 9 previous prospective studies to examine the overall evidence for a relationship of prediagnostic serum IGF‐I with colorectal cancer risk. In the EPIC study, serum concentrations of IGF‐I and IGFBP‐3 showed no associations with risk of colorectal cancer overall. Only in subgroup analyses did our study show moderate positive associations of IGF‐I levels with risk, either among younger participants only (and only for colon cancer) or among participants whose milk intakes were in the lowest tertile of the population distribution (RR for an increase of 100 ng/ml = 1.43 [95% CI = 1.13–1.93]). Nevertheless, in the meta‐analysis a modest positive association remained between serum IGF‐I and colorectal cancer risk overall (RR = 1.07 [1.01–1.14] for 1 standard deviation increase in IGF‐I). Overall, data from our present study and previous prospective studies combined indicate a relatively modest association of colorectal cancer risk with serum IGF‐I.


Cancer Causes & Control | 2007

Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition

Christine M. Friedenreich; Anne E. Cust; Petra H. Lahmann; Karen Steindorf; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sylvie Mesrine; Jakob Linseisen; Sabine Rohrmann; Heiner Boeing; Tobias Pischon; Anne Tjønneland; Jytte Halkjær; Kim Overvad; Michelle A. Mendez; María-Luisa Redondo; Carmen Martinez Garcia; Nerea Larrañaga; María José Tormo; Aurelio Barricarte Gurrea; Sheila Bingham; Kay-Tee Khaw; Naomi E. Allen; Timothy J. Key; Antonia Trichopoulou; Effie Vasilopoulou; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino

ObjectiveTo examine the association between anthropometry and endometrial cancer, particularly by menopausal status and exogenous hormone use subgroups.MethodsAmong 223,008 women in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, there were 567 incident endometrial cancer cases during 6.4 years of follow-up. The analysis was performed with Cox proportional hazards modeling.ResultsWeight, body mass index (BMI), waist and hip circumferences and waist–hip ratio (WHR) were strongly associated with increased risk of endometrial cancer. The relative risk (RR) for obese (BMI 30– < 40 kg/m2) compared to normal weight (BMI < 25) women was 1.78, 95% CI = 1.41–2.26, and for morbidly obese women (BMI ≥ 40) was 3.02, 95% CI = 1.66–5.52. The RR for women with a waist circumference of ≥88 cm vs. <80 cm was 1.76, 95% CI = 1.42–2.19. Adult weight gain of ≥20 kg compared with stable weight (±3 kg) increased risk independent of body weight at age 20 (RR = 1.75, 95% CI = 1.11–2.77). These associations were generally stronger for postmenopausal than premenopausal women, and oral contraceptives never-users than ever-users, and much stronger among never-users of hormone replacement therapy compared to ever-users.ConclusionObesity, abdominal adiposity, and adult weight gain were strongly associated with endometrial cancer risk. These associations were particularly evident among never-users of hormone replacement therapy.


International Journal of Cancer | 2006

Fruits and vegetables and renal cell carcinoma: Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)

Steffen Weikert; Heiner Boeing; Tobias Pischon; Anja Olsen; Anne Tjønneland; Kim Overvad; Nikolaus Becker; J. Linseisen; Petra H. Lahmann; Athina Arvaniti; Christina Kassapa; Antonia Trichoupoulou; Sabina Sieri; Domenico Palli; Rosario Tumino; Paolo Vineis; Salvatore Panico; Carla H. van Gils; Petra H.M. Peeters; H. Bas Bueno-de-Mesquita; Frederike L. Büchner; Börje Ljungberg; Göran Hallmans; Göran Berglund; Elisabet Wirfält; Guillem Pera; Miren Dorronsoro; Aurelio Barricarte Gurrea; Carmen Navarro; Carmen Martinez

We examined the association between fruits and vegetables and risk of renal cell carcinoma (RCC) in the European Prospective Investigation into Cancer and Nutrition (EPIC). Dietary intake data and complete follow‐up information on cancer incidence were available for 375,851 participants recruited in EPIC centers of 8 countries. During an average follow‐up of 6.2 years, 306 incident cases of RCC were identified. The associations of consumption of total vegetables, total fruits, combined total fruits and vegetables and specific subtypes of vegetables with RCC risk were analyzed using Cox proportional hazards, stratified by centre and adjusted for potential confounders. No significant associations between fruit and vegetable consumption and RCC risk were observed despite a wide range of intake. The estimated relative risks (95% confidence intervals [CI]) in men and women combined were 0.97 (0.85–1.11) per 40 g increase in vegetable intake, 1.03 (0.97–1.08) per 40 g increase in fruit intake and 1.02 (0.93–1.11) per 80 g increase in fruit and vegetable intake combined. Among the vegetable subtypes, an inverse association was observed for root vegetables (RR per 8 g increase: 0.88; 95% CI: 0.78–0.99). These results suggest that total consumption of fruits and vegetables is not related to risk of RCC, although we cannot exclude the possibility that very low consumption is related to higher risk. The relationship of specific fruit and vegetable subgroups with RCC risk warrant further investigation.


International Journal of Cancer | 2009

Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Nina Føns Johnsen; Anne Tjønneland; Birthe L. Thomsen; Jane Christensen; Steffen Loft; Christine M. Friedenreich; Timothy J. Key; Naomi E. Allen; Petra H. Lahmann; Lotte Mejlvig; Kim Overvad; Rudolf Kaaks; Sabine Rohrmann; Heiner Boing; Gesthimani Misirli; Antonia Trichopoulou; Dimosthenis Zylis; Rosario Tumino; Valeria Pala; H. Bas Bueno-de-Mesquita; Lambertus A. Kiemeney; Laudina Rodríguez Suárez; Carlos A. González; María José Sánchez; José María Huerta; Aurelio Barricarte Gurrea; Jonas Manjer; Elisabet Wirfält; Kay-Tee Khaw; Nicholas J. Wareham

The evidence concerning the possible association between physical activity and the risk of prostate cancer is inconsistent and additional data are needed. We examined the association between risk of prostate cancer and physical activity at work and in leisure time in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. In our study, including 127,923 men aged 20–97 years from 8 European countries, 2,458 cases of prostate cancer were identified during 8.5 years of followup. Using the Cox proportional hazards model, we investigated the associations between prostate cancer incidence rate and occupational activity and leisure time activity in terms of participation in sports, cycling, walking and gardening; a metabolic equivalent (MET) score based on weekly time spent on the 4 activities; and a physical activity index. MET hours per week of leisure time activity, higher score in the physical activity index, participation in any of the 4 leisure time activities, and the number of leisure time activities in which the participants were active were not associated with prostate cancer incidence. However, higher level of occupational physical activity was associated with lower risk of advanced stage prostate cancer (ptrend = 0.024). In conclusion, our data support the hypothesis of an inverse association between advanced prostate cancer risk and occupational physical activity, but we found no support for an association between prostate cancer risk and leisure time physical activity.


The American Journal of Clinical Nutrition | 2012

Fruit and vegetable consumption and prospective weight change in participants of the European Prospective Investigation into Cancer and Nutrition–Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating Out of Home, and Obesity study

Anne Claire Vergnaud; Teresa Norat; Dora Romaguera; Traci Mouw; Anne M. May; Isabelle Romieu; Heinz Freisling; Nadia Slimani; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Brian Buijsse; Anne Tjønneland; Jytte Halkjær; Kim Overvad; Marianne Uhre Jakobsen; Laudina Rodríguez; Antonio Agudo; Maria José Sánchez; Pilar Amiano; José María Huerta; Aurelio Barricarte Gurrea; Nicholas J. Wareham; Kay-Tee Khaw; Francesca L. Crowe; Philippos Orfanos; Androniki Naska

BACKGROUND Fruit and vegetable consumption might prevent weight gain through their low energy density and high dietary fiber content. OBJECTIVE We assessed the association between the baseline consumption of fruit and vegetables and weight change in participants from 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition study. DESIGN Diet was assessed at baseline in 373,803 participants by using country-specific validated questionnaires. Weight was measured at baseline and self-reported at follow-up in most centers. Associations between baseline fruit and vegetable intakes (per 100 g/d) and weight change (g/y) after a mean follow-up of 5 y were assessed by using linear mixed-models, with age, sex, total energy intake, and other potential confounders controlled for. RESULTS After exclusion of subjects with chronic diseases at baseline and subjects who were likely to misreport energy intakes, baseline fruit and vegetable intakes were not associated with weight change overall. However, baseline fruit and vegetable intakes were inversely associated with weight change in men and women who quit smoking during follow-up. We observed weak positive associations between vegetable intake and weight change in women who were overweight, were former smokers, or had high prudent dietary pattern scores and weak inverse associations between fruit intake and weight change in women who were >50 y of age, were of normal weight, were never smokers, or had low prudent dietary pattern scores. CONCLUSIONS In this large study, higher baseline fruit and vegetable intakes, while maintaining total energy intakes constant, did not substantially influence midterm weight change overall but could help to reduce risk of weight gain in persons who stop smoking. The interactions observed in women deserve additional attention.


The American Journal of Clinical Nutrition | 2011

Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Eric J. Duell; Noémie Travier; Leila Lujan-Barroso; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sophie Morois; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; J. Ramón Quirós; Emilio Sánchez-Cantalejo; Carmen Navarro; Aurelio Barricarte Gurrea; Miren Dorronsoro; Kay-Tee Khaw; Naomi E. Allen; Timothy J. Key; H. Bas Bueno-de-Mesquita; Martine M. Ros; Mattijs E. Numans; Petra H.M. Peeters; Antonia Trichopoulou; Androniki Naska; Vardis Dilis; Birgit Teucher; Rudolf Kaaks; Heiner Boeing; Madlen Schütze

BACKGROUND Gastric cancer (GC) is the second leading cause of cancer death worldwide. The association between alcohol consumption and GC has been investigated in numerous epidemiologic studies with inconsistent results. OBJECTIVE We evaluated the association between alcohol consumption and GC risk. DESIGN We conducted a prospective analysis in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, which included 444 cases of first primary gastric adenocarcinoma. HRs and 95% CIs for GC were estimated by using multivariable Cox proportional hazards regression for consumption of pure ethanol in grams per day, with stratification by smoking status, anatomic subsite (cardia, noncardia), and histologic subtype (diffuse, intestinal). In a subset of participants, results were further adjusted for baseline Helicobacter pylori serostatus. RESULTS Heavy (compared with very light) alcohol consumption (≥60 compared with 0.1-4.9 g/d) at baseline was positively associated with GC risk (HR: 1.65; 95% CI: 1.06, 2.58), whereas lower consumption amounts (<60 g/d) were not. When we analyzed GC risk by type of alcoholic beverage, there was a positive association for beer (≥30 g/d; HR: 1.75; 95% CI: 1.13, 2.73) but not for wine or liquor. Associations were primarily observed at the highest amounts of drinking in men and limited to noncardia subsite and intestinal histology; no statistically significant linear dose-response trends with GC risk were observed. CONCLUSION Heavy (but not light or moderate) consumption of alcohol at baseline (mainly from beer) is associated with intestinal-type noncardia GC risk in men from the EPIC cohort.


The American Journal of Clinical Nutrition | 2012

Coffee and tea consumption and the risk of ovarian cancer : a prospective cohort study and updated meta-analysis

Marieke G.M. Braem; N. Charlotte Onland-Moret; Leo J. Schouten; Anne Tjønneland; Louise Hansen; Christina C. Dahm; Kim Overvad; Annekatrin Lukanova; Laure Dossus; Anna Floegel; Heiner Boeing; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet; Guy Fagherazzi; Antonia Trichopoulou; Vassiliki Benetou; Ioulia Goufa; Valeria Pala; Rocco Galasso; Amalia Mattiello; Carlotta Sacerdote; Domenico Palli; Rosario Tumino; Inger Torhild Gram; Eiliv Lund; Oxana Gavrilyuk; Maria José Sánchez; Ramón Quirós; Carlos Gonzales; Miren Dorronsoro

BACKGROUND In 2007 the World Cancer Research Fund Report concluded that there was limited and inconsistent evidence for an effect of coffee and tea consumption on the risk of epithelial ovarian cancer (EOC). OBJECTIVE In the European Prospective Investigation into Cancer and Nutrition (EPIC), we aimed to investigate whether coffee intakes, tea intakes, or both are associated with the risk of EOC. DESIGN All women participating in the EPIC (n = 330,849) were included in this study. Data on coffee and tea consumption were collected through validated food-frequency questionnaires at baseline. HRs and 95% CIs were estimated by using Cox proportional hazards models. Furthermore, we performed an updated meta-analysis of all previous prospective studies until April 2011 by comparing the highest and lowest coffee- and tea-consumption categories as well as by using dose-response random-effects meta-regression analyses. RESULTS During a median follow-up of 11.7 y, 1244 women developed EOC. No association was observed between the risk of EOC and coffee consumption [HR: 1.05 (95% CI: 0.75, 1.46) for the top quintile compared with no intake] or tea consumption [HR: 1.07 (95% CI: 0.78, 1.45) for the top quintile compared with no intake]. This lack of association between coffee and tea intake and EOC risk was confirmed by the results of our meta-analysis. CONCLUSION Epidemiologic studies do not provide sufficient evidence to support an association between coffee and tea consumption and risk of ovarian cancer.


British Journal of Cancer | 2012

Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort

Verena Grote; R. Kaaks; Alexandra Nieters; Anne Tjønneland; Jytte Halkjær; Kim Overvad; M R Skjelbo Nielsen; M. C. Boutron-Ruault; F. Clavel-Chapelon; Antoine Racine; Birgit Teucher; Susen Becker; Tobias Pischon; Heiner Boeing; Antonia Trichopoulou; C Cassapa; V Stratigakou; Domenico Palli; V. Krogh; R. Tumino; Paolo Vineis; Salvatore Panico; L. Rodriguez; Eric J. Duell; Sánchez M-J.; Miren Dorronsoro; C. Navarro; Aurelio Barricarte Gurrea; Peter D. Siersema; Peeters Phm.

Background:Established risk factors for pancreatic cancer include smoking, long-standing diabetes, high body fatness, and chronic pancreatitis, all of which can be characterised by aspects of inflammatory processes. However, prospective studies investigating the relation between inflammatory markers and pancreatic cancer risk are scarce.Methods:We conducted a nested case–control study within the European Prospective Investigation into Cancer and Nutrition, measuring prediagnostic blood levels of C-reactive protein (CRP), interleukin-6 (IL-6), and soluble receptors of tumour necrosis factor-α (sTNF-R1, R2) in 455 pancreatic cancer cases and 455 matched controls. Odds ratios (ORs) were estimated using conditional logistic regression models.Results:None of the inflammatory markers were significantly associated with risk of pancreatic cancer overall, although a borderline significant association was observed for higher circulating sTNF-R2 (crude OR=1.52 (95% confidence interval (CI) 0.97–2.39), highest vs lowest quartile). In women, however, higher sTNF-R1 levels were significantly associated with risk of pancreatic cancer (crude OR=1.97 (95% CI 1.02–3.79)). For sTNF-R2, risk associations seemed to be stronger for diabetic individuals and those with a higher BMI.Conclusion:Prospectively, CRP and IL-6 do not seem to have a role in our study with respect to risk of pancreatic cancer, whereas sTNF-R1 seemed to be a risk factor in women and sTNF-R2 might be a mediator in the risk relationship between overweight and diabetes with pancreatic cancer. Further large prospective studies are needed to clarify the role of proinflammatory proteins and cytokines in the pathogenesis of exocrine pancreatic cancer.


International Journal of Cancer | 2015

Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.

Katharina Nimptsch; Krasimira Aleksandrova; Heiner Boeing; Jürgen Janke; Young-Ae Lee; Mazda Jenab; H. B. Bueno-de-Mesquita; Eugene Jansen; Konstantinos K. Tsilidis; Antonia Trichopoulou; Elisabete Weiderpass; Chun Sen Wu; Kim Overvad; Anne Tjønneland; Marie-Christine Boutron-Ruault; Laure Dossus; Antoine Racine; Rudolf Kaaks; Federico Canzian; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Claudia Agnoli; Rosario Tumino; Paolo Vineis; Salvatore Panico; Anders Johansson; Bethany Van Guelpen; Kay-Tee Khaw; Nicholas J. Wareham

High blood concentrations of C‐reactive protein (CRP) have been associated with elevated risk of colorectal cancer in several prospective studies including the European Prospective Investigation into Cancer and Nutrition (EPIC), but it is unknown whether these observations reflect a causal relationship. We aimed to investigate whether CRP genetic variants associated with lifelong higher CRP concentrations translate into higher colorectal cancer risk. We conducted a prospective nested case–control study within EPIC including 727 cases diagnosed between 1992 and 2003 and 727 matched controls selected according to an incidence‐density sampling protocol. Baseline CRP concentrations were measured in plasma samples by a high sensitivity assay. Tagging single nucleotide polymorphisms (SNPs) in the CRP gene (rs1205, rs1800947, rs1130864, rs2808630, rs3093077) were identified via HapMap. The causal effect of CRP on colorectal cancer risk was examined in a Mendelian Randomization approach utilizing multiple CRP genetic variants as instrumental variables. The SNPs rs1205, rs1800947, rs1130864 and rs3093077 were significantly associated with CRP concentrations and were incorporated in a CRP allele score which was associated with 13% higher CRP concentrations per allele count (95% confidence interval 8–19%). Using the CRP‐score as instrumental variable, genetically twofold higher CRP concentrations were associated with higher risk of colorectal cancer (odds ratio 1.74, 95% confidence interval 1.06–2.85). Similar observations were made using alternative definitions of instrumental variables. Our findings give support to the hypothesis that elevated circulating CRP may play a direct role in the etiology of colorectal cancer.

Collaboration


Dive into the Aurelio Barricarte Gurrea's collaboration.

Top Co-Authors

Avatar

Antonia Trichopoulou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heiner Boeing

Free University of Berlin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rosario Tumino

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Salvatore Panico

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Vineis

Imperial College London

View shared research outputs
Top Co-Authors

Avatar

Kay-Tee Khaw

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar

Rudolf Kaaks

German Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge